Evidence map›Paper›PMID 33918329›Full record

ArticlePharmaceutics2021

Ginsenoside Absorption Rate and Extent Enhancement of Black Ginseng (CJ EnerG) over Red Ginseng in Healthy Adults.

Saebyul Yoo, Bom-I Park, Do-Hyun Kim, Sooyoung Lee, Seung-Hoon Lee, Wang-Seob Shim, Yong Ki Seo, Kimoon Kang, Kyung-Tae Lee, Sung-Vin Yim and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04932265 (Dissolution and Pharmacokinetic of Ginsenosides Released From Cyclodextrin Based Chewable Tablets), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04932265 phase1suspendednot on this map

Dissolution and Pharmacokinetic of Ginsenosides Released From Cyclodextrin Based Chewable Tablets: a Comparative, Randomized, Crossover, Open-label Study in Healthy Human Subjects.

TypeinterventionalSponsorEuroPharma, Inc.Ran2021 to 2025Enrolled3ConditionsDrug AbsorptionArmsHRG80™ Red Ginseng, HRG80™ Red Ginseng + gamma cyclodextrin
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Saebyul YooDepartment of Biomedical Science and Technology, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Bom-I ParkFood Research Institutes, CJ CheilJedang, Suwon 16495, Korea.
Do-Hyun KimDepartment of Biomedical Science and Technology, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Sooyoung LeeDepartment of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Seung-Hoon LeeDepartment of Statistics, lnha University, Incheon 22212, Korea.
Wang-Seob ShimKyung Hee Drug Analysis Center, College of Pharmacy, Medical Center, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-0903-1386
Yong Ki SeoFood Research Institutes, CJ CheilJedang, Suwon 16495, Korea.
Kimoon KangFood Research Institutes, CJ CheilJedang, Suwon 16495, Korea.
Kyung-Tae LeeDepartment of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-3141-3727
Sung-Vin YimDepartment of Clinical Pharmacology and Therapeutics, Kyung Hee University Medical Center, Seoul 02447, Korea.ORCID 0000-0003-4393-800X
Do Yu SoungFood Research Institutes, CJ CheilJedang, Suwon 16495, Korea.
Bo-Hyung KimDepartment of Biomedical Science and Technology, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Kyung Hee University · KRCJ CheilJedang (South Korea) · KRKyung Hee University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red ginseng (RG) and black ginseng (BG, CJ EnerG) were prepared from fresh ginseng using one and nine cycles of steaming and drying, respectively. This process reduces the molecular weight (MW) of ginsenoside-active compounds in ginseng by removing sugar moieties from their dammaranes. We compared the pharmacokinetic characteristics of ginsenosides between BG comprising mainly low-MW ginsenosides (Rg3, Rg5, Rk1, and Rh1) and RG that predominantly contains high-MW ginsenosides (Rb1, Rb2, Rc, Rd, Re, and Rg1). The safety profiles and tolerability were also studied using a randomized, double-blind, single-dose, crossover clinical trial. A combination of Rb1, Rg1, and Rg3, well-known representative and functional RG components, exhibited a 1 h faster absorption rate (T

Indexed as

black ginsengginsenosidespharmacokinetics

Identifiers

PMID33918329
PMCPMC8067055
OpenAlexW3140570637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.